Propranolol is a nonselective beta-adrenergic receptor blocker (beta-blocker) that is widely used for the therapy of hypertension, cardiac arrhythmias, angina pectoris and hyperthyroidism
3 – 5 However, despite the fact that reduction in cardiovascular morbidity and mortality in hypertension is largely driven by treatment-induced BP changes, 6,7 cardiovascular protection offered by β-blockers is weaker than
Propranolol is a beta blocker originally synthesized in the 1960s by James W
Non-cardioselective beta blockers, like propranolol or nadolol, helps minimize arrhythmias, blood pressure, heart rate, and the workload on the heart
None of the trials showed clear worsening effects Beta-blockers have been used to alleviate some symptoms of anxiety; probably patients with palpitation, tremor, and tachycardia respond best
Endocrine
In keeping with this, long-term administration of a nonselective β-blocker to steroid-naïve asthma patients has shown a dose-dependent improvement in airway
Non-selective beta-blockers (NSBBs) are the established cornerstone of treatment for prevention of first bleeding and rebleeding of oesophageal varices in patients with cirrhosis
23, 28 Thus, a major part of the efficacy of propranolol in patients Drowsiness
Myoclonus (spasmodic, jerky, muscle contractions) Paresthesias (abnormal sensations or prickling in the nerves) NSBBs were first shown to reduce portal pressure in patients with variceal hemorrhage in 1980